Clinical Medicine


  Listando 98 trabajos del autor/autora 38
Lista de trabajos en el área Clinical Medicine
Mentions   0   Wikipedia   95   News   0   Policy
Article Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37298 women with early breast cancer in 26 randomised trials Boddington, C.; Bradley, R.; Braybrooke, J.; Burrett, J.; Clarke, M.; Davies, C.; Davies, L.; Dodwell, D.; Duane, F.; Evans, V.; Gettins, L.; Godwin, J.; Gray, R.; Hills, R.; James, S.; Liu, H.; Liu, Z.; MacKinnon, E.; Mannu, G.; McGale, P.; McHugh, T.; Mo LANCET 0140-6736 (2019) DOI / 10.1016/s0140-6736(18)33137-4 Green published, Green accepted, Gold other
Mentions   0   Wikipedia   110   News   0   Policy
Article Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone Sestak, Ivana; Martin, Miguel; Dubsky, Peter; Kronenwett, Ralf; Rojo, Federico; Cuzick, Jack; Filipits, Martin; Ruiz, Amparo; Gradishar, William; Soliman, Hatem; Schwartzberg, Lee; Buus, Richard; Hlauschek, Dominik; Rodriguez-Lescure, Alvaro; Gnant, Michae BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2019) DOI / 10.1007/s10549-019-05226-8 Green published, Gold other
Mentions   0   Wikipedia   50   News   0   Policy
Article 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer Kalinsky, Kevin; Barlow, William E.; Gralow, Julie R.; Meric-Bernstam, Funda; Albain, Kathy S.; Hayes, Daniel F.; Lin, Nancy U.; Perez, Edith A.; Goldstein, Lori J.; Chia, Stephen K. L.; Dhesy-Thind, Sukhbinder; Rastogi, Priya; Alba, Emilio; Delaloge, Suze NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2021) DOI / 10.1056/nejmoa2108873
Mentions   0   Wikipedia   50   News   0   Policy
Article Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation Litton, Jennifer K.; Rugo, Hope S.; Ettl, Johannes; Hurvitz, Sara A.; Goncalves, Anthony; Lee, Kyung-Hun; Fehrenbacher, Louis; Yerushalmi, Rinat; Mina, Lida A.; Martin, Miguel; Roche, Henri; Im, Young-Hyuck; Quek, Ruben G. W.; Markova, Denka; Tudor, Iulia NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2018) DOI / 10.1056/nejmoa1802905 Bronze
Mentions   0   Wikipedia   34   News   0   Policy
Article Trajectories of alcohol consumption during life and the risk of developing breast cancer Donat-Vargas, Carolina; Guerrero-Zotano, Angel; Casas, Ana; Manuel Baena-Canada, Jose; Lope, Virginia; Antolin, Silvia; Angel Garcia-Saenz, Jose; Bermejo, Begona; Munoz, Montserrat; Ramos, Manuel; de Juan, Ana; Jara Sanchez, Carlos; Sanchez-Rovira, Pedro; BRITISH JOURNAL OF CANCER 0007-0920 (2021) DOI / 10.1038/s41416-021-01492-w Hybrid
Mentions   0   Wikipedia   74   News   0   Policy
Article Abemaciclib Combined With Endocrine Therapy for the Adjuvant Treatment of HR+, HER2-, Node-Positive, High-Risk, Early Breast Cancer (monarchE) Johnston, Stephen R. D.; Harbeck, Nadia; Hegg, Roberto; Toi, Masakazu; Martin, Miguel; Shao, Zhi Min; Zhang, Qing Yuan; Martinez Rodriguez, Jorge Luis; Campone, Mario; Hamilton, Erika; Sohn, Joohyuk; Guarneri, Valentina; Okada, Morihito; Boyle, Frances; Ne JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.20.02514 Gold other
Mentions   0   Wikipedia   45   News   0   Policy
Article Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial Martin, Miguel; Holmes, Frankie A.; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von Minckwitz, Gunter; Chia, Stephen K. L.; Mansi, Janine; Barrios, Carlos H.; Gnant, Michael; Tomasevic, Zorica; Denduluri, Neelima; Separovic, Robert; Go LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30717-9
Mentions   0   Wikipedia   47   News   0   Policy
Article Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial Chan, Arlene; Moy, Beverly; Mansi, Janine; Ejlertsen, Bent; Holmes, Frankie Ann; Chia, Stephen; Iwata, Hiroji; Gnant, Michael; Loibl, Sibylle; Barrios, Carlos H.; Somali, Isil; Smichkoska, Snezhana; Martinez, Noelia; Alonso, Mirta Garcia; Link, John S.; Ma CLINICAL BREAST CANCER 1526-8209 (2021) DOI / 10.1016/j.clbc.2020.09.014 Green published, Gold other
Mentions   0   Wikipedia   26   News   3   Policy
Article Phase III Randomized Study of Ribociclib and Fulvestrant in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer: MONALEESA-3 Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia Val; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; de la Cruz-Merino, Luis; Beck, J. Tha JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2018) DOI / 10.1200/jco.2018.78.9909
Mentions   0   Wikipedia   18   News   0   Policy
Article Neoadjuvant Trastuzumab Emtansine and Pertuzumab in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer: Three-Year Outcomes From the Phase III KRISTINE Study Hurvitz, Sara A.; Martin, Miguel; Jung, Kyung Hae; Huang, Chiun-Sheng; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois; Fasching, Peter A.; Afenjar, Karen; Spera, Gonzalo; Lopez-Valverde, Vanes JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2019) DOI / 10.1200/jco.19.00882 Green published, Gold other
Mentions   0   Wikipedia   2   News   0   Policy
Article Exercise and cancer: a position statement from the Spanish Society of Medical Oncology Pollan, M.; Casla-Barrio, S.; Alfaro, J.; Esteban, C.; Segui-Palmer, M. A.; Lucia, A.; Martin, M. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-020-02312-y Green published, Hybrid
Mentions   0   Wikipedia   16   News   0   Policy
Article Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial Pernas, Sonia; Martin, Miguel; Kaufman, Peter A.; Gil-Martin, Marta; Gomez Pardo, Patricia; Lopez-Tarruella, Sara; Manso, Luis; Ciruelos, Eva; Alejandro Perez-Fidalgo, Jose; Hernando, Cristina; Ademuyiwa, Foluso O.; Weilbaecher, Katherine; Mayer, Ingrid; P LANCET ONCOLOGY 1470-2045 (2018) DOI / 10.1016/s1470-2045(18)30147-5
Mentions   0   Wikipedia   9   News   0   Policy
Article Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer Schettini, Francesco; Chic, Nuria; Braso-Maristany, Fara; Pare, Laia; Pascual, Tomas; Conte, Benedetta; Martinez-Saez, Olga; Adamo, Barbara; Vidal, Maria; Barnadas, Esther; Fernandez-Martinez, Aranzazu; Gonzalez-Farre, Blanca; Sanfeliu, Esther; Cejalvo, Ju NPJ BREAST CANCER (2021) DOI / 10.1038/s41523-020-00208-2 Green published, Gold
Mentions   0   Wikipedia   14   News   0   Policy
Article Quality of life with talazoparib versus physician's choice of chemotherapy in patients wits advanced breast cancer and germline BRCA1/2 mutation: patient-reported outcomes from the EMBRACA ease III trial Ettl, J.; Quek, R. G. W.; Lee, K. -H.; Rugo, H. S.; Hurvitz, S.; Goncalves, A.; Fehrenbacher, L.; Yerushalmi, R.; Mina, L. A.; Martin, M.; Roche, H.; Im, Y. -H.; Markova, D.; Bhattacharyya, H.; Hannah, A. L.; Eiermann, W.; Blum, J. L.; Litton, J. K. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy257 Bronze
Mentions   0   Wikipedia   15   News   2   Policy
Article Neoadjuvant trastuzumab, pertuzumab, and chemotherapy versus trastuzumab emtansine plus pertuzumab in patients with HER2-positive breast cancer (KRISTINE): a randomised, open-label, multicentre, phase 3 trial Hurvitz, Sara A.; Martin, Miguel; Symmans, W. Fraser; Jung, Kyung Hae; Huang, Chiun-Sheng; Thompson, Alastair M.; Harbeck, Nadia; Valero, Vicente; Stroyakovskiy, Daniil; Wildiers, Hans; Campone, Mario; Boileau, Jean-Francois; Beckmann, Matthias W.; Afenjar LANCET ONCOLOGY 1470-2045 (2018) DOI / 10.1016/s1470-2045(17)30716-7
Mentions   0   Wikipedia   10   News   2   Policy
Article Overall Survival with Ribociclib plus Fulvestrant in Advanced Breast Cancer Slamon, Dennis J.; Neven, Patrick; Chia, Stephen; Fasching, Peter A.; De Laurentiis, Michelino; Im, Seock-Ah; Petrakova, Katarina; Bianchi, Giulia V.; Esteva, Francisco J.; Martin, Miguel; Nusch, Arnd; Sonke, Gabe S.; de la Cruz-Merino, Luis; Beck, J. Thad NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2020) DOI / 10.1056/nejmoa1911149 Bronze
Mentions   0   Wikipedia   6   News   0   Policy
Article Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01) Lluch, Ana; Barrios, Carlos H.; Torrecillas, Laura; Ruiz-Borrego, Manuel; Bines, Jose; Segalla, Jose; Guerrero-Zotano, Angel; Garcia-Saenz, Jose A.; Torres, Roberto; de la Haba, Juan; Garcia-Martinez, Elena; Gomez, Henry L.; Llombart, Antonio; Salvador Bof JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.19.00904 Gold other
Mentions   0   Wikipedia   10   News   0   Policy
Article Prognostic characteristics in hormone receptor-positive advanced breast cancer and characterization of abemaciclib efficacy Di Leo, Angelo; O'Shaughnessy, Joyce; Sledge, George W., Jr.; Martin, Miguel; Lin, Yong; Frenzel, Martin; Hardebeck, Molly C.; Smith, Ian C.; Llombart-Cussac, Antonio; Goetz, Matthew P.; Johnston, Stephen NPJ BREAST CANCER (2018) DOI / 10.1038/s41523-018-0094-2 Gold DOAJ, Green published
Mentions   0   Wikipedia   6   News   0   Policy
Article Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial Loibl, Sibylle; Marme, Frederik; Martin, Miguel; Untch, Michael; Bonnefoi, Herve; Kim, Sung-Bae; Bear, Harry; McCarthy, Nicole; Mele Olive, Mireia; Gelmon, Karen; Garcia-Saenz, Jose; Kelly, Catherine M.; Reimer, Toralf; Toi, Masakazu; Rugo, Hope S.; Denker JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2021) DOI / 10.1200/jco.20.03639
Mentions   0   Wikipedia   5   News   0   Policy
Article Efficacy of Chemotherapy for ER-Negative and ER-Positive Isolated Locoregional Recurrence of Breast Cancer: Final Analysis of the CALOR Trial Wapnir, Irene L.; Price, Karen N.; Anderson, Stewart J.; Robidoux, Andre; Martin, Miguel; Nortier, Johan W. R.; Paterson, Alexander H. G.; Rimawi, Mothaffar F.; Lang, Istvan; Manuel Baena-Canada, Jose; Thurlimann, Beat; Mamounas, Eleftherios P.; Geyer, Cha JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2018) DOI / 10.1200/jco.2017.76.5719 Green published
Mentions   0   Wikipedia   5   News   0   Policy
Article Physical activity and breast cancer risk by pathological subtype Lope, Virginia; Martin, Miguel; Castello, Adela; Casla, Soraya; Ruiz, Amparo; Manuel Baena-Canada, Jose; Ma Casas, Ana; Calvo, Lourdes; Bermejo, Begona; Munoz, Montserrat; Ramos, Manuel; De Juan-Ferre, Ana; Jara, Carlos; Anton, Antonio; Angeles Jimeno, Ma; GYNECOLOGIC ONCOLOGY 0090-8258 (2017) DOI / 10.1016/j.ygyno.2016.12.014
Mentions   1   Wikipedia   6   News   1   Policy
Article MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer Johnston, Stephen; Martin, Miguel; Di Leo, Angelo; Im, Seock-Ah; Awada, Ahmad; Forrester, Tammy; Frenzel, Martin; Hardebeck, Molly C.; Cox, Joanne; Barriga, Susana; Toi, Masakazu; Iwata, Hiroji; Goetz, Matthew P. NPJ BREAST CANCER (2019) DOI / 10.1038/s41523-018-0097-z Gold other, Green published
Mentions   0   Wikipedia   3   News   0   Policy
Article Adjuvant denosumab in early breast cancer (D-CARE): an international, multicentre, randomised, controlled, phase 3 trial Coleman, Robert; Finkelstein, Dianne M.; Barrios, Carlos; Martin, Miguel; Iwata, Hiroji; Hegg, Roberto; Glaspy, John; Montano Perianez, Alvaro; Tonkin, Katia; Deleu, Ines; Sohn, Joohyuk; Crown, John; Delaloge, Suzette; Dai, Tian; Zhou, Ying; Jandial, Danie LANCET ONCOLOGY 1470-2045 (2020) DOI / 10.1016/s1470-2045(19)30687-4
Mentions   0   Wikipedia   4   News   3   Policy
Article Trastuzumab Emtansine With or Without Pertuzumab Versus Trastuzumab Plus Taxane for Human Epidermal Growth Factor Receptor 2-Positive, Advanced Breast Cancer: Primary Results From the Phase III MARIANNE Study Perez, Edith A.; Barrios, Carlos; Eiermann, Wolfgang; Toi, Masakazu; Im, Young-Hyuck; Conte, Pierfranco; Martin, Miguel; Pienkowski, Tadeusz; Pivot, Xavier; Burris, Howard, III; Petersen, Jennifer A.; Stanzel, Sven; Strasak, Alexander; Patre, Monika; Ellis JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2017) DOI / 10.1200/jco.2016.67.4887 Gold other, Green published
Mentions   0   Wikipedia   2   News   0   Policy
Article Survival impact of primary tumor resection in de novo metastatic breast cancer patients (GEICAM/El Alamo Registry) Lopez-Tarruella, Sara; Escudero, M. J.; Pollan, Marina; Martin, Miguel; Jara, Carlos; Bermejo, Begona; Guerrero-Zotano, Angel; Garcia-Saenz, Jose; Santaballa, Ana; Alba, Emilio; Andres, Raquel; Martinez, Purificacion; Calvo, Lourdes; Fernandez, Antonio; Ba SCIENTIFIC REPORTS 2045-2322 (2019) DOI / 10.1038/s41598-019-55765-9 Gold DOAJ, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Outcomes of COVID-19 in Patients With Lung Cancer Treated in a Tertiary Hospital in Madrid Calles, Antonio; Inmaculada Aparicio, Maria; Alva, Manuel; Bringas, Marianela; Gutierrez, Natalia; Soto, Javier; Arregui, Marta; Clara Tirado, Victoria; Luis Alvarez, Enrique; del Monte-Millan, Maria; Massarrah, Tatiana; Galera, Mar; Alvarez, Rosa; Martin, FRONTIERS IN ONCOLOGY 2234-943X (2020) DOI / 10.3389/fonc.2020.01777 Green published, Gold
Mentions   0   Wikipedia   4   News   0   Policy
Article Overeating, caloric restriction and breast cancer risk by pathologic subtype: the EPIGEICAM study Lope, Virginia; Martin, Miguel; Castello, Adela; Ruiz, Amparo; Casas, Ana M.; Manuel Baena-Canada, Jose; Antolin, Silvia; Ramos-Vazquez, Manuel; Angel Garcia-Saenz, Jose; Munoz, Montserrat; Lluch, Ana; De Juan-Ferre, Ana; Jara, Carlos; Sanchez-Rovira, Pedr SCIENTIFIC REPORTS 2045-2322 (2019) DOI / 10.1038/s41598-019-39346-4 Gold DOAJ, Green published
Mentions   0   Wikipedia   4   News   0   Policy
Article Palbociclib in combination with endocrine therapy versus capecitabine in hormonal receptor-positive, human epidermal growth factor 2-negative, aromatase inhibitor-resistant metastatic breast cancer: a phase III randomised controlled trial-PEARL Martin, M.; Zielinski, C.; Ruiz-Borrego, M.; Carrasco, E.; Turner, N.; Ciruelos, E. M.; Munoz, M.; Bermejo, B.; Margeli, M.; Anton, A.; Kahan, Z.; Csoszi, T.; Casas, M., I; Murillo, L.; Morales, S.; Alba, E.; Gal-Yam, E.; Guerrero-Zotano, A.; Calvo, L.; de ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2020.12.013 Green published, Gold other
Mentions   0   Wikipedia   3   News   3   Policy
Article Impact of palbociclib plus letrozole on patient-reported health-related quality of life: results from the PALOMA-2 trial Rugo, H. S.; Dieras, V.; Gelmon, K. A.; Finn, R. S.; Slamon, D. J.; Martin, M.; Neven, P.; Shparyk, Y.; Mori, A.; Lu, D. R.; Bhattacharyya, H.; Bartlett, C. Huang; Iyer, S.; Johnston, S.; Ettl, J.; Harbeck, N. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy012 Green published, Gold other
Mentions   0   Wikipedia   0   News   2   Policy
Article Clinical considerations of the role of palbociclib in the management of advanced breast cancer patients with and without visceral metastases Turner, N. C.; Finn, R. S.; Martin, M.; Im, S. -A; DeMichele, A.; Ettl, J.; Dieras, V.; Moulder, S.; Lipatov, O.; Colleoni, M.; Cristofanilli, M.; Lu, D. R.; Mori, A.; Giorgetti, C.; Iyer, S.; Bartlett, C. Huang; Gelmon, K. A. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdx797 Gold other, Green published
Mentions   0   Wikipedia   1   News   1   Policy
Article Oncological care organisation during COVID-19 outbreak Onesti, Concetta Elisa; Rugo, Hope S.; Generali, Daniele; Peeters, Marc; Zaman, Khalil; Wildiers, Hans; Harbeck, Nadia; Martin, Miguel; Cristofanilli, Massimo; Cortes, Javier; Tjan-Heijnen, Vivianne; Hurvitz, Sara A.; Berchem, Guy; Tagliamento, Marco; Camp ESMO OPEN (2020) DOI / 10.1136/esmoopen-2020-000853 Green published, Gold
Mentions   0   Wikipedia   1   News   0   Policy
Article Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling Martin, M.; de la Torre-Montero, J. C.; Lopez-Tarruella, S.; Pinilla, K.; Casado, A.; Fernandez, S.; Jerez, Y.; Puente, J.; Palomero, I.; Gonzalez del Val, R.; del Monte-Millan, M.; Massarrah, T.; Vila, C.; Garcia-Paredes, B.; Garcia-Saenz, J. A.; Lluch, A BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2018) DOI / 10.1007/s10549-018-4855-2 Gold other, Green published
Mentions   0   Wikipedia   1   News   0   Policy
Article Primary breast cancer and health related quality of life in Spanish women: The EpiGEICAM case-control study Fernandez de Larrea-Baz, Nerea; Perez-Gomez, Beatriz; Guerrero-Zotano, Angel; Maria Casas, Ana; Bermejo, Begona; Manuel Baena-Canada, Jose; Antolin, Silvia; Sanchez-Rovira, Pedro; Ramos Vazquez, Manuel; Angel Garcia-Saenz, Jose; Anton, Antonio; Munoz, Mont SCIENTIFIC REPORTS 2045-2322 (2020) DOI / 10.1038/s41598-020-63637-w Green published, Gold other
Mentions   0   Wikipedia   3   News   0   Policy
Article Original Research Health-related quality of life with palbociclib plus endocrine therapy versus capecitabine in postmenopausal patients with hormone receptor-positive metastatic breast cancer: Patient-reported outcomes in the PEARL study Kahan, Zsuzsanna; Gil-Gil, Miguel; Ruiz-Borrego, Manuel; Carrasco, Eva; Ciruelos, Eva; Munoz, Montserrat; Bermejo, Begona; Margeli, Mireia; Anton, Antonio; Casas, Maribel; Csoszi, Tibor; Murillo, Laura; Morales, Serafin; Calvo, Lourdes; Lang, Istvan; Alba, EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.07.004 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article A Pathology-Based Combined Model to Identify PAM50 Non-luminal Intrinsic Disease in Hormone Receptor-Positive HER2-Negative Breast Cancer Pascual, Tomas; Martin, Miguel; Fernandez-Martinez, Aranzazu; Pare, Laia; Alba, Emilio; Rodriguez-Lescure, Alvaro; Perrone, Giuseppe; Cortes, Javier; Morales, Serafin; Lluch, Ana; Urruticoechea, Ander; Gonzalez-Farre, Blanca; Galvan, Patricia; Jares, Pedro FRONTIERS IN ONCOLOGY 2234-943X (2019) DOI / 10.3389/fonc.2019.00303 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Pathological Response and Survival in Triple-Negative Breast Cancer Following Neoadjuvant Carboplatin plus Docetaxel Sharma, Priyanka; Lopez-Tarruella, Sara; Angel Garcia-Saenz, Jose; Khan, Qamar J.; Gomez, Henry L.; Prat, Aleix; Moreno, Fernando; Jerez-Gilarranz, Yolanda; Barnadas, Agusti; Picornell, Antoni C.; del Monte-Millan, Maria; Gonzalez-Rivera, Milagros; Massarr CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-18-0585 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Severe toxicity to capecitabine due to a new variant at a donor splicing site in the dihydropyrimidine dehydrogenase (DPYD) gene Garcia-Gonzalez, Xandra; Lopez-Tarruella, Sara; Isabel Garcia, Maria; Gonzalez-Haba, Eva; Blanco, Carolina; Salvador-Martin, Sara; Jerez, Yolanda; Thomas, Fabienne; Jarama, Maria; Sanjurjo Saez, Maria; Martin, Miguel; Andres Lopez-Fernandez, Luis CANCER MANAGEMENT AND RESEARCH 1179-1322 (2018) DOI / 10.2147/cmar.s174470 Gold DOAJ, Green published
Mentions   0   Wikipedia   2   News   0   Policy
Article Trastuzumab emtansine with or without pertuzumab versus trastuzumab with taxane for human epidermal growth factor receptor 2-positive advanced breast cancer: Final results from MARIANNE Perez, Edith A.; Barrios, Carlos; Eiermann, Wolfgang; Toi, Masakazu; Im, Young-Hyuck; Conte, Pierfranco; Martin, Miguel; Pienkowski, Tadeusz; Pivot, Xavier B.; Burris, Howard A., III; Petersen, Jennifer A.; de Haas, Sanne; Hoersch, Silke; Patre, Monika; El CANCER 0008-543X (2019) DOI / 10.1002/cncr.32392 Green published, Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article GEICAMGuidelines for the Management of Patients with Breast Cancer During theCOVID-19 Pandemic in Spain Martin, Miguel; Guerrero-Zotano, Angel; Montero, Angel; Jara, Carlos; Filipovich, Elena; Rojo, Federico; Moreno, Fernando; Angel Garcia-Saenz, Jose; Enrique Ales, Jose; Ignacio Chacon, Jose; Cruz, Josefina; Gimenez, Julia; Cruz-Merino, Luis; Algara, Manel; ONCOLOGIST 1083-7159 (2020) DOI / 10.1634/theoncologist.2020-0363 Gold other, Green published
Mentions   0   Wikipedia   3   News   0   Policy
Article Potent Cell-Cycle Inhibition and Upregulation of Immune Response with Abemaciclib and Anastrozole in neoMONARCH, Phase II Neoadjuvant Study in HR+/HER2(-) Breast Cancer Hurvitz, Sara A.; Martin, Miguel; Press, Michael F.; Chan, David; Fernandez-Abad, Maria; Petru, Edgar; Rostorfer, Regan; Guarneri, Valentina; Huang, Chiun-Sheng; Barriga, Susana; Wijayawardana, Sameera; Brahmachary, Manisha; Ebert, Philip J.; Hossain, Anwa CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-1425 Bronze, Green accepted
Mentions   0   Wikipedia   1   News   1   Policy
Article Efficacy of Neoadjuvant Carboplatin plus Docetaxel in Triple-Negative Breast Cancer: Combined Analysis of Two Cohorts Sharma, Priyanka; Lopez-Tarruella, Sara; Angel Garcia-Saenz, Jose; Ward, Claire; Connor, Carol S.; Gomez, Henry L.; Prat, Aleix; Moreno, Fernando; Jerez-Gilarranz, Yolanda; Barnadas, Augusti; Picornell, Antoni C.; del Monte-Millan, Maria; Gonzalez-Rivera, CLINICAL CANCER RESEARCH 1078-0432 (2017) DOI / 10.1158/1078-0432.ccr-16-0162 Green accepted, Bronze
Mentions   0   Wikipedia   2   News   0   Policy
Article Talazoparib versus chemotherapy in patients with germline BRCA1/2-mutated HER2-negative advanced breast cancer: final overall survival results from the EMBRACA trial Litton, J. K.; Hurvitz, S. A.; Mina, L. A.; Rugo, H. S.; Lee, K-H; Goncalves, A.; Diab, S.; Woodward, N.; Goodwin, A.; Yerushalmi, R.; Roch, H.; Im, Y-H; Eiermann, W.; Quek, R. G. W.; Usari, T.; Lanzalone, S.; Czibere, A.; Blum, J. L.; Martin, M.; Ettl, J. ANNALS OF ONCOLOGY 0923-7534 (2020) DOI / 10.1016/j.annonc.2020.08.2098 Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Article Poor Prognosis After Second Locoregional Recurrences in the CALOR Trial Wapnir, Irene L.; Gelber, Shari; Anderson, Stewart J.; Mamounas, Eleftherios P.; Robidoux, Andre; Martin, Miguel; Nortier, Johan W. R.; Geyer, Charles E., Jr.; Paterson, Alexander H. G.; Lang, Istvan; Price, Karen N.; Coates, Alan S.; Gelber, Richard D.; R ANNALS OF SURGICAL ONCOLOGY 1068-9265 (2017) DOI / 10.1245/s10434-016-5571-y Green accepted
Mentions   0   Wikipedia   1   News   0   Policy
Article Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH Garrido, P.; Aldaz, A.; Vera, R.; Calleja, M. A.; de Alava, E.; Martin, M.; Matias-Guiu, X.; Palacios, J. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-017-1740-0 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Association Between ABCB1 Genetic Variants and Persistent Chemotherapy-Induced Alopecia in Women With Breast Cancer Nunez-Torres, Rocio; Martin, Miguel; Garcia-Saenz, Jose Angel; Rodrigo-Faus, Maria; del Monte-Millan, Maria; Tejera-Perez, Hugo; Pita, Guillermo; de la Torre-Montero, Julio C.; Pinilla, Karen; Herraez, Belen; Peiro-Chova, Lorena; Bermejo, Begona; Lluch, An JAMA DERMATOLOGY 2168-6068 (2020) DOI / 10.1001/jamadermatol.2020.1867
Mentions   2   Wikipedia   1   News   0   Policy
Article A randomized adaptive phase II/III study of buparlisib, a pan-class I PI3K inhibitor, combined with paclitaxel for the treatment of HER2-advanced breast cancer (BELLE-4) Martin, M.; Chan, A.; Dirix, L.; O'shaughnessy, J.; Hegg, R.; Manikhas, A.; Shtivelband, M.; Krivorotko, P.; Batista Lopez, N.; Campone, M.; Ruiz Borrego, M.; Khan, Q. J.; Beck, J. T.; Ramos Vazquez, M.; Urban, P.; Goteti, S.; di Tomaso, E.; Massacesi, C.; ANNALS OF ONCOLOGY 0923-7534 (2017) DOI / 10.1093/annonc/mdw562 Bronze
Mentions   0   Wikipedia   1   News   0   Policy
Article Ribociclib plus fulvestrant for postmenopausal women with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer in the phase III randomized MONALEESA-3 trial: updated overall survival Slamon, D. J.; Neven, P.; Chia, S.; Jerusalem, G.; De Laurentiis, M.; Im, S.; Petrakova, K.; Bianchi, G. Valeria; Martin, M.; Nusch, A.; Sonke, G. S.; De la Cruz-Merino, L.; Beck, J. T.; Ji, Y.; Wang, C.; Deore, U.; Chakravartty, A.; Zarate, J. P.; Taran, ANNALS OF ONCOLOGY 0923-7534 (2021) DOI / 10.1016/j.annonc.2021.05.353 Hybrid
Mentions   0   Wikipedia   1   News   0   Policy
Article IMpassion132 Phase III trial: atezolizumab and chemotherapy in early relapsing metastatic triple-negative breast cancer Cortes, Javier; Andre, Fabrice; Goncalves, Anthony; Kuemmel, Sherko; Martin, Miguel; Schmid, Peter; Schuetz, Florian; Swain, Sandra M.; Easton, Valerie; Pollex, Erika; Deurloo, Regula; Dent, Rebecca FUTURE ONCOLOGY 1479-6694 (2019) DOI / 10.2217/fon-2019-0059
Mentions   0   Wikipedia   0   News   0   Policy
Article Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial Delaloge, S.; Cella, D.; Ye, Y.; Buyse, M.; Chan, A.; Barrios, C. H.; Holmes, F. A.; Mansi, J.; Iwata, H.; Ejlertsen, B.; Moy, B.; Chia, S. K. L.; Gnant, M.; Smichkoska, S.; Ciceniene, A.; Martinez, N.; Filipovic, S.; Ben-Baruch, N. E.; Joy, A. A.; Langkje ANNALS OF ONCOLOGY 0923-7534 (2019) DOI / 10.1093/annonc/mdz016 Gold other
Mentions   0   Wikipedia   1   News   0   Policy
Editorial Material Tuning up adjuvant endocrine therapy: the TEAM trial Martin, Miguel LANCET ONCOLOGY 1470-2045 (2017) DOI / 10.1016/s1470-2045(17)30462-x
Mentions   0   Wikipedia   0   News   0   Policy
Article Frequency of breast cancer with hereditary risk features in Spain: Analysis from GEICAM "ElA Alamo III" retrospective study Marquez-Rodas, Ivan; Pollan, Marina; Jose Escudero, Maria; Ruiz, Amparo; Martin, Miguel; Santaballa, Ana; Martinez del Prado, Purificacion; Batista, Norberto; Andres, Raquel; Anton, Antonio; Llombart, Antonio; Fernandez Aramburu, Antonio; Adrover, Encarnac PLOS ONE 1932-6203 (2017) DOI / 10.1371/journal.pone.0184181 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   1   Policy
Article First-line vs second-line fulvestrant for hormone receptor-positive advanced breast cancer: A post-hoc analysis of the CONFIRM study Di Leo, Angelo; Jerusalem, Guy; Torres, Roberto; Verhoeven, Didier; Pendergrass, Kelly; Malorni, Luca; Lichfield, Jasmine; Martin, Miguel BREAST 0960-9776 (2018) DOI / 10.1016/j.breast.2017.12.016
Mentions   0   Wikipedia   0   News   0   Policy
Review Abemaciclib, a CDK4 and CDK6 inhibitor for the treatment of metastatic breast cancer Martin, Miguel; Garcia-Saenz, Jose A.; Manso, Luis; Llombart, Antonio; Cassinello, Alejo; Atienza, Manuel; Ringeisen, Francois; Ciruelos, Eva FUTURE ONCOLOGY 1479-6694 (2020) DOI / 10.2217/fon-2020-0604 Hybrid
Mentions   0   Wikipedia   0   News   0   Policy
Article Assessment of ERBB2/HER2 Status in HER2-Equivocal Breast Cancers by FISH and 2013/2014 ASCO-CAP Guidelines Press, Michael F.; Seoane, Jose A.; Curtis, Christina; Quinaux, Emmanuel; Guzman, Roberta; Sauter, Guido; Eiermann, Wolfgang; Mackey, John R.; Robert, Nicholas; Pienkowski, Tadeusz; Crown, John; Martin, Miguel; Valero, Vicente; Bee, Valerie; Ma, Yanling; V JAMA ONCOLOGY 2374-2437 (2019) DOI / 10.1001/jamaoncol.2018.6012 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Concordance of Genomic Variants in Matched Primary Breast Cancer, Metastatic Tumor, and Circulating Tumor DNA: The MIRROR Study Moreno, Fernando; Gayarre, Javier; Lopez-Tarruella, Sara; del Monte-Millan, Maria; Picornell, Antonio C.; Alvarez, Enrique; Angel Garcia-Saenz, Jose; Jerez, Yolanda; Marquez-Rodas, Ivan; Echavarria, Isabel; Palomero, Maribel; Bueno, Coralia; Aragon Bodi, A JCO PRECISION ONCOLOGY (2019) DOI / 10.1200/po.18.00263
Mentions   0   Wikipedia   0   News   0   Policy
Article Randomised phase III trial of vinflunine plus capecitabine versus capecitabine alone in patients with advanced breast cancer previously treated with an anthracycline and resistant to taxane Martin, M.; Campone, M.; Bondarenko, I; Sakaeva, D.; Krishnamurthy, S.; Roman, L.; Lebedeva, L.; Vedovato, J-C; Aapro, M. ANNALS OF ONCOLOGY 0923-7534 (2018) DOI / 10.1093/annonc/mdy063 Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Biomarker Analyses of Response to Cyclin-Dependent Kinase 4/6 Inhibition and Endocrine Therapy in Women with Treatment-Naive Metastatic Breast Cancer Finn, Richard S.; Liu, Yuan; Zhu, Zhou; Martin, Miguel; Rugo, Hope S.; Dieras, Veronique; Im, Seock-Ah; Gelmon, Karen A.; Harbeck, Nadia; Lu, Dongrui R.; Gauthier, Eric; Bartlett, Cynthia Huang; Slamon, Dennis J. CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-19-0751 Bronze
Mentions   0   Wikipedia   0   News   1   Policy
Article Prospective, multicenter study on the economic and clinical impact of gene-expression assays in early-stage breast cancer from a single region: the PREGECAM registry experience Perez Ramirez, S.; del Monte-Millan, M.; Lopez-Tarruella, S.; Martinez Janez, N.; Marquez-Rodas, I; Lobo Samper, F.; Izarzugaza Peron, Y.; Rubio Terres, C.; Rubio Rodriguez, D.; Garcia-Saenz, J. A.; Moreno Anton, F.; Zamora Aunon, P.; Arroyo Yustos, M.; La CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-019-02176-x
Mentions   0   Wikipedia   0   News   0   Policy
Article The MAGIC survey in hormone receptor positive (HR+), HER2-negative (HER2-) breast cancer: When might multigene assays be of value? Aapro, Matti; De Laurentiis, Michelino; Rea, Dan; Bargallo Rocha, Juan Enrique; Elizalde, Roberto; Landherr, Laszlo; Linderholm, Barbro; Mamounas, Eleftherios; Markopoulos, Christos; Neven, Patrick; Petrovsky, Alexander; Rouzier, Roman; Smit, Vincent; Sved BREAST 0960-9776 (2017) DOI / 10.1016/j.breast.2017.01.012
Mentions   0   Wikipedia   0   News   1   Policy
Article Multivariable clinical-genetic risk model for predicting venous thromboembolic events in patients with cancer Munoz Martin, Andres J.; Ortega, Israel; Font, Carme; Pachon, Vanesa; Castellon, Victoria; Martinez-Marin, Virginia; Salgado, Mercedes; Martinez, Eva; Calzas, Julia; Ruperez, Ana; Souto, Juan C.; Martin, Miguel; Salas, Eduardo; Soria, Jose M. BRITISH JOURNAL OF CANCER 0007-0920 (2018) DOI / 10.1038/s41416-018-0027-8 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Equity, barriers and cancer disparities: study of the Spanish Society of Medical Oncology on the access to oncologic drugs in the Spanish Regions Salvador, J.; Urtasun, J. A.; Duart, F. J. B.; Garcia-Campelo, R.; Carbonero, R. G.; Lianes, P.; Llombart, A.; Casado, D. I.; Piera, J. M.; Mateu, M. M.; Puente, J.; Rivera, F.; Rodriguez, C. A.; Virizuela, J. A.; Martin, M.; Garrido, P. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2017) DOI / 10.1007/s12094-016-1535-8 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Review Strategies to design clinical studies to identify predictive biomarkers in cancer research Perez-Gracia, Jose Luis; Sanmamed, Miguel F.; Bosch, Ana; Patino-Garcia, Ana; Schalper, Kurt A.; Segura, Victor; Bellmunt, Joaquim; Tabernero, Josep; Sweeney, Christopher J.; Choueiri, Toni K.; Martin, Miguel; Pablo Fusco, Juan; Esperanza Rodriguez-Ruiz, M CANCER TREATMENT REVIEWS 0305-7372 (2017) DOI / 10.1016/j.ctrv.2016.12.005 Gold other, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article A PAM50-Based Chemoendocrine Score for Hormone Receptor-Positive Breast Cancer with an Intermediate Risk of Relapse Prat, Aleix; Lluch, Ana; Turnbull, Arran K.; Dunbier, Anita K.; Calvo, Lourdes; Albanell, Joan; de la Haba-Rodriguez, Juan; Arcusa, Angels; Ignacio Chacon, Jose; Sanchez-Rovira, Pedro; Plazaola, Arrate; Munoz, Montserrat; Pare, Laia; Parker, Joel S.; Ribel CLINICAL CANCER RESEARCH 1078-0432 (2017) DOI / 10.1158/1078-0432.ccr-16-2092 Bronze, Green accepted, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer Gerber, David E.; Infante, Jeffrey R.; Gordon, Michael S.; Goldberg, Sarah B.; Martin, Miguel; Felip, Enriqueta; Martinez Garcia, Maria; Schiller, Joan H.; Spigel, David R.; Cordova, Julie; Westcott, Valerie; Wang, Yulei; Shames, David S.; Choi, YounJeong; CLINICAL CANCER RESEARCH 1078-0432 (2020) DOI / 10.1158/1078-0432.ccr-18-3965
Mentions   0   Wikipedia   0   News   0   Policy
Article Abemaciclib as initial therapy for advanced breast cancer: MONARCH 3 updated results in prognostic subgroups Johnston, Stephen; O'Shaughnessy, Joyce; Martin, Miguel; Huober, Jens; Toi, Masakazu; Sohn, Joohyuk; Andre, Valerie A. M.; Martin, Holly R.; Hardebeck, Molly C.; Goetz, Matthew P. NPJ BREAST CANCER (2021) DOI / 10.1038/s41523-021-00289-7 Gold DOAJ
Mentions   0   Wikipedia   0   News   0   Policy
Article Pathological Response in a Triple-Negative Breast Cancer Cohort Treated with Neoadjuvant Carboplatin and Docetaxel According to Lehmann's Refined Classification Echavarria, Isabel; Lopez-Tarruella, Sara; Picornell, Antoni; Angel Garcia-Saenz, Jose; Jerez, Yolanda; Hoadley, Katherine; Gomez, Henry L.; Moreno, Fernando; del Monte-Millan, Maria; Marquez-Rodas, Ivan; Alvarez, Enrique; Ramos-Medina, Rocio; Gayarre, Jav CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-17-1912 Bronze, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Review Biomarkers in breast cancer: A consensus statement by the Spanish Society of Medical Oncology and the Spanish Society of Pathology Colomer, R.; Aranda-Lopez, I.; Albanell, J.; Garcia-Caballero, T.; Ciruelos, E.; Lopez-Garcia, M. A.; Cortes, J.; Rojo, F.; Martin, M.; Palacios-Calvo, J. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-017-1800-5 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Aggressiveness of end-of-life cancer care: what happens in clinical practice? Garcia-Martin, Estela; Escudero-Vilaplana, Vicente; Fox, Barbara; Collado-Borrell, Roberto; Marzal-Alfaro, Belen; Sanchez-Isac, Maria; Solano-Garzon, Maria Luisa; Gonzalez Del Val, Ricardo; Cano-Gonzalez, Jose Manuel; Perez de Lucas, Nuria; Bravo-Guillen, SUPPORTIVE CARE IN CANCER 0941-4355 (2020) DOI / 10.1007/s00520-020-05828-9
Mentions   0   Wikipedia   0   News   0   Policy
Article Etiology and Prognosis of Pneumonia in Patients with Solid Tumors: A Prospective Cohort of Hospitalized Cases Fernandez-Cruz, Ana; Ortega, Laura; Garcia, Gonzalo; Gallego, Iria; Alarez-Uria, Ana; Chamorro-de-Vega, Esther; Javier Garcia-Lopez, Jese; Gonzalez-del-Val, Ricardo; Martin-Rabadan, Pablo; Rodriguez, Carmen; Pedro-Botet, Maria Liisa; Martin, Miguel; Bouza, ONCOLOGIST 1083-7159 (2020) DOI / 10.1634/theoncologist.2019-0031 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Neratinib for the treatment of early-stage, hormone receptor-positive, HER2-overexpressed breast cancer Jerez, Yolanda; Herrero, Blanca; Arregui, Marta; Moron, Blanca; Martin, Miguel; Echavarria, Isabel FUTURE ONCOLOGY 1479-6694 (2020) DOI / 10.2217/fon-2020-0046
Mentions   0   Wikipedia   0   News   0   Policy
Article DPYD Exome, mRNA Expression and Uracil Levels in Early Severe Toxicity to Fluoropyrimidines: An Extreme Phenotype Approach Villalvazo, Priscila; Marzal-Alfaro, Belen; Garcia-Alfonso, Pilar; Luis Revuelta-Herrero, Jose; Thomas, Fabienne; Lopez-Tarruella, Sara; Garcia-Gonzalez, Xandra; Calvo, Aitana; Yakoubi, Malika; Salvador-Martin, Sara; Lopez-Lopez, Flora; Aguilar, Iker; Sanj JOURNAL OF PERSONALIZED MEDICINE (2021) DOI / 10.3390/jpm11080792 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Editorial Material Biosimilars Martin, Miguel ESMO OPEN (2018) DOI / 10.1136/esmoopen-2018-000321 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Evaluating the addition of bevacizumab to endocrine therapy as first-line treatment for hormone receptor-positive metastatic breast cancer: a pooled analysis from the LEA (GEICAM/2006-11_GBG51) and CALGB 40503 (Alliance) trials Martin, M.; Loibl, S.; Hyslop, T.; de la Haba-Rodriguez, J.; Aktas, B.; Cirrincione, C. T.; Mehta, K.; Barry, W. T.; Morales, S.; Carey, L. A.; Garcia-Saenz, J. A.; Partridge, A.; Martinez-Janez, N.; Hahn, O.; Winer, E.; Guerrero-Zotano, A.; Hudis, C.; Cas EUROPEAN JOURNAL OF CANCER 0959-8049 (2019) DOI / 10.1016/j.ejca.2019.06.002 Gold other, Green accepted
Mentions   0   Wikipedia   0   News   0   Policy
Article Clinical Trial Curigliano, Giuseppe; Martin, Miguel; Jhaveri, Komal; Beck, J. T.; Tortora, Giampaolo; Fazio, Nicola; Maur, Michela; Hubner, Richard A.; Lahner, Harald; Donnet, Valerie; Ajipa, Olga; Li, Zheng; Blumenstein, Lars; Andre, Fabrice EUROPEAN JOURNAL OF CANCER 0959-8049 (2021) DOI / 10.1016/j.ejca.2021.03.042
Mentions   0   Wikipedia   0   News   0   Policy
Article Neoadjuvant Management of Early Breast Cancer: A Clinical and Investigational Position Statement Colomer, Ramon; Saura, Cristina; Sanchez-Rovira, Pedro; Pascual, Tomas; Rubio, Isabel T.; Burgues, Octavio; Marcos, Lourdes; Rodriguez, Cesar A.; Martin, Miguel; Lluch, Ana ONCOLOGIST 1083-7159 (2019) DOI / 10.1634/theoncologist.2018-0228 Green published, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article Outcomes of single versus double hormone receptor-positive breast cancer. A GEICAM/9906 sub-study Ethier, J. L.; Ocana, A.; Rodriguez Lescure, A.; Ruiz, A.; Alba, E.; Calvo, L.; Ruiz-Borrego, M.; Santaballa, A.; Rodriguez, C. A.; Crespo, C.; Ramos, M.; Gracia Marco, J.; Lluch, A.; Alvarez, I.; Casas, M.; Sanchez-Arago, M.; Carrasco, E.; Caballero, R.; EUROPEAN JOURNAL OF CANCER 0959-8049 (2018) DOI / 10.1016/j.ejca.2018.02.018
Mentions   0   Wikipedia   0   News   0   Policy
Article Health-RelatedQuality of Life inMONARCH3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy inHR+,HER2-Advanced Breast Cancer Goetz, Matthew P.; Martin, Miguel; Tokunaga, Eriko; Park, In Hae; Huober, Jens; Toi, Masakazu; Stoffregen, Clemens; Shekarriz, Sarah; Andre, Valerie; Gainford, M. Corona; Price, Gregory L.; Johnston, Stephen ONCOLOGIST 1083-7159 (2020) DOI / 10.1634/theoncologist.2020-0084 Green published, Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Ribociclib plus fulvestrant for advanced breast cancer: Health-related quality-of-life analyses from the MONALEESA-3 study Fasching, Peter A.; Beck, J. Thaddeus; Chan, Arlene; De Laurentiis, Michele; Esteva, Francisco J.; Jerusalem, Guy; Neven, Patrick; Pivot, Xavier; Bianchi, Giulia V.; Martin, Miguel; Chandiwana, David; Lanoue, Brad; Ridol, Antonia; Wang, Yingbo; Lorenc, Kar BREAST 0960-9776 (2020) DOI / 10.1016/j.breast.2020.09.008 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Review A clinical calculator to predict disease outcomes in women with hormone receptor-positive advanced breast cancer treated with first-line endocrine therapy Polley, Mei-Yin C.; Dickler, Maura N.; Sinnwell, Jason; Tenner, Kathleen; de la Haba, Juan; Loibl, Sibylle; Goetz, Matthew P.; Bergh, Jonas; Roberston, John; Couch, Fergus; Ellis, Matthew J.; Martin, Miguel BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2021) DOI / 10.1007/s10549-021-06319-z
Mentions   0   Wikipedia   0   News   0   Policy
Article Limitations in predicting PAM50 intrinsic subtype and risk of relapse score with Ki67 in estrogen receptor-positive HER2-negative breast cancer Fernandez-Martinez, Aranzazu; Pascual, Tomas; Perrone, Giuseppe; Morales, Serafin; de la Haba, Juan; Gonzalez-Rivera, Milagros; Galvan, Patricia; Zalfa, Francesca; Amato, Michela; Gonzalez, Lucia; Prats, Miquel; Rojo, Federico; Manso, Luis; Pare, Laia; Alo ONCOTARGET 1949-2553 (2017) DOI / 10.18632/oncotarget.15748 Bronze, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Prognostic role for the derived neutrophil-to-lymphocyte ratio in early breast cancer: a GEICAM/9906 substudy Templeton, A. J.; Rodriguez-Lescure, A.; Ruiz, A.; Alba, E.; Calvo, L.; Ruiz-Borrego, M.; Santaballa, A.; Rodriguez, C. A.; Crespo, C.; Ramos, M.; Gracia-Marco, J. M.; Lluch, A.; Alvarez, I.; Casas, M. I.; Sanchez-Arago, M.; Caballero, R.; Carrasco, E.; Am CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2018) DOI / 10.1007/s12094-018-1885-5
Mentions   0   Wikipedia   0   News   0   Policy
Article Evaluation of Breast Cancer Patients with Genetic Risk in a University Hospital: Before and After the Implementation of a Heredofamilial Cancer Unit Lobo, Miriam; Lopez-Tarruella, Sara; Luque, Soledad; Lizarraga, Santiago; Flores-Sanchez, Carmen; Bueno, Oscar; Solera, Jesus; Jerez, Yolanda; Gonzalez Del Val, Ricardo; Isabel Palomero, Maria; Cebollero, Maria; Echavarria, Isabel; Torres, Gabriela; Martin JOURNAL OF GENETIC COUNSELING 1059-7700 (2018) DOI / 10.1007/s10897-017-0187-3
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study Ruiz-Borrego, Manuel; Guerrero-Zotano, Angel; Bermejo, Begona; Ramos, Manuel; Cruz, Josefina; Manuel Baena-Canada, Jose; Cirauqui, Beatriz; Rodriguez-Lescure, Alvaro; Alba, Emilio; Martinez-Janez, Noelia; Munoz, Montserrat; Antolin, Silvia; Alvarez, Isabel BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2019) DOI / 10.1007/s10549-019-05296-8
Mentions   0   Wikipedia   0   News   0   Policy
Article Phase I Study of CC-486 Alone and in Combination with Carboplatin or nab-Paclitaxel in Patients with Relapsed or Refractory Solid Tumors Von Hoff, Daniel D.; Rasco, Drew W.; Heath, Elisabeth I.; Munster, Pamela N.; Schellens, Jan H. M.; Isambert, Nicolas; Le Tourneau, Christophe; O'Neill, Bert; Mathijssen, Ron H. J.; Lopez-Martin, Jose A.; Edenfiele, W. Jeff; Martin, Miguel; LoRusso, Patric CLINICAL CANCER RESEARCH 1078-0432 (2018) DOI / 10.1158/1078-0432.ccr-17-3716 Green accepted, Bronze
Mentions   0   Wikipedia   0   News   0   Policy
Article PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial Chia, Stephen K. L.; Martin, Miguel; Holmes, Frankie A.; Ejlertsen, Bent; Delaloge, Suzette; Moy, Beverly; Iwata, Hiroji; von Minckwitz, Gunter; Mansi, Janine; Barrios, Carlos H.; Gnant, Michael; Tomasevic, Zorica; Denduluri, Neelima; Separovic, Robert; Ki BREAST CANCER RESEARCH 1465-542X (2019) DOI / 10.1186/s13058-019-1115-2 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Assessment of diarrhea as side effect of oral targeted antineoplastic agents in clinical practice Escudero-Vilaplana, Vicente; Collado-Borrell, Roberto; del Monte-Millan, Maria; Hoyo-Munoz, Angela; Gomez Martinez-Sagrera, Patricia; Revuelta-Herrero, Jose Luis; Marzal-Alfaro, Belen; Gonzalez-Haba, Eva; Lopez-Tarruella Cobo, Sara; Jerez Gilarranz, Yoland SUPPORTIVE CARE IN CANCER 0941-4355 (2021) DOI / 10.1007/s00520-021-06016-z
Mentions   0   Wikipedia   0   News   0   Policy
Article nextMONARCH: Abemaciclib Monotherapy or Combined With Tamoxifen for Metastatic Breast Cancer Hamilton, Erika; Cortes, Javier; Ozyilkan, Ozgur; Chen, Shin-Cheh; Petrakova, Katarina; Manikhas, Aleksey; Jerusalem, Guy; Hegg, Roberto; Huober, Jens; Chapman, Sonya C.; Lu, Yi; Hardebeck, Molly C.; Bear, Melissa M.; Johnston, Erica L.; Martin, Miguel CLINICAL BREAST CANCER 1526-8209 (2021) DOI / 10.1016/j.clbc.2020.09.011
Mentions   0   Wikipedia   0   News   0   Policy
Letter Suggestions Regarding the GEICAM/2003-11_CIBOMA/2004-01 Trial: Future Treatment Options for Early Triple-Negative Breast Cancer Reply Lluch, Ana; Barrios, Carlos H.; Torrecillas, Laura; Martin, Miguel JOURNAL OF CLINICAL ONCOLOGY 0732-183X (2020) DOI / 10.1200/jco.20.00390
Mentions   0   Wikipedia   0   News   0   Policy
Review Technical Challenges for CTC Implementation in Breast Cancer Ramos-Medina, Rocio; Lopez-Tarruella, Sara; del Monte-Millan, Maria; Massarrah, Tatiana; Martin, Miguel CANCERS (2021) DOI / 10.3390/cancers13184619 Green published, Gold
Mentions   0   Wikipedia   0   News   0   Policy
Review Incorporating CDK4/6 Inhibitors in the Treatment of Advanced Luminal Breast Cancer Echavarria, Isabel; Jerez, Yolanda; Martin, Miguel; Lopez-Tarruella, Sara BREAST CARE 1661-3791 (2017) DOI / 10.1159/000481656 Bronze, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Progression-free Survival Outcome Is Independent of Objective Response in Patients With Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative Advanced Breast Cancer Treated With Palbociclib Plus Letrozole Compared With Letrozole: An Rugo, Hope S.; Finn, Richard S.; Gelmon, Karen; Joy, Anil A.; Harbeck, Nadia; Castrellon, Aurelio; Mukai, Hirofumi; Walshe, Janice M.; Mori, Ave; Gauthier, Eric; Lu, Dongrui Ray; Bananis, Eustratios; Martin, Miguel; Dieras, Veronique CLINICAL BREAST CANCER 1526-8209 (2020) DOI / 10.1016/j.clbc.2019.08.009 Gold other
Mentions   0   Wikipedia   0   News   0   Policy
Article Everolimus plus exemestane in hormone-receptor-positive, HER2-negative locally advanced or metastatic breast cancer: incidence and time course of adverse events in the phase IIIb BALLET population Ciruelos, E.; Jerusalem, G.; Martin, M.; Tjan-Heijnen, V. C. G.; Neven, P.; Gavila, J.; Montemurro, F.; Generali, D.; Lang, I.; Martinez-Serrano, M. J.; Perello, M. F.; Conte, P. CLINICAL & TRANSLATIONAL ONCOLOGY 1699-048X (2020) DOI / 10.1007/s12094-020-02327-5
Mentions   0   Wikipedia   0   News   0   Policy
Review At the bedside: Profiling and treating patients with CXCR4-expressing cancers Martin, Miguel; Mayer, Ingrid A.; Walenkamp, Annemiek M. E.; Lapa, Constantin; Andreeff, Michael; Bobirca, Alexandra JOURNAL OF LEUKOCYTE BIOLOGY 0741-5400 (2020) DOI / 10.1002/jlb.5bt1219-714r
Mentions   0   Wikipedia   0   News   0   Policy
Article Multicenter analysis of neoadjuvant docetaxel, carboplatin, and trastuzumab in HER2-positive breast cancer Echavarria, Isabel; Granja, Monica; Bueno, Coralia; Lopez-Tarruella, Sara; Peinado, Paloma; Sotelo, Miguel; Jerez, Yolanda; Moreno, Fernando; Torres, Gabriela; Lobo, Miriam; Marquez-Rodas, Ivan; del Monte-Millan, Maria; Martin, Miguel; Angel Garcia-Saenz, BREAST CANCER RESEARCH AND TREATMENT 0167-6806 (2017) DOI / 10.1007/s10549-016-4098-z
Mentions   0   Wikipedia   0   News   0   Policy
Article Neratinib for the treatment of HER2-positive early stage breast cancer Echavarria, Isabel; Lopez-Tarruella, Sara; Marquez-Rodas, Ivan; Jerez, Yolanda; Martin, Miguel EXPERT REVIEW OF ANTICANCER THERAPY 1473-7140 (2017) DOI / 10.1080/14737140.2017.1338954
Mentions   0   Wikipedia   0   News   0   Policy
Article Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis Martin, Miguel; Chacon, Jose I.; Anton, Antonio; Plazaola, Arrate; Garcia-Martinez, Elena; Segui, Miguel A.; Sanchez-Rovira, Pedro; Palacios, Jose; Calvo, Lourdes; Esteban, Carmen; Espinosa, Enrique; Barnadas, Agusti; Batista, Norberto; Guerrero, Angel; Mu ONCOLOGIST 1083-7159 (2017) DOI / 10.1634/theoncologist.2017-0052 Bronze, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Activity of docetaxel, carboplatin, and doxorubicin in patient-derived triple-negative breast cancer xenografts Martin, Miguel; Ramos-Medina, Rocio; Bernat, Rebeca; Angel Garcia-Saenz, Jose; del Monte-Millan, Maria; Alvarez, Enrique; Cebollero, Maria; Moreno, Fernando; Gonzalez-Haba, Eva; Bueno, Oscar; Romero, Paula; Massarrah, Tatiana; Echavarria, Isabel; Jerez, Yo SCIENTIFIC REPORTS 2045-2322 (2021) DOI / 10.1038/s41598-021-85962-4 Gold DOAJ, Green published
Mentions   0   Wikipedia   0   News   0   Policy
Article Ribociclib for the treatment of advanced hormone receptor-positive, HER2-negative breast cancer Lopez-Tarruella, Sara; Jerez, Yolanda; Marquez-Rodas, Ivan; Echavarria, Isabel; Martin, Miguel FUTURE ONCOLOGY 1479-6694 (2017) DOI / 10.2217/fon-2017-0183

Más rankings

InfluScience